Joinn Laboratories(China)Co.,Ltd.
603127
Rang in aandelen
#3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Aandeelprijs
$6.82
Marktkapitalisatie
$4.30B
Verandering (1 dag)
-6.30%
Verandering (1 jaar)
48.79%
Land
CN
Handel Joinn Laboratories(China)Co.,Ltd. (603127)
Categorie
Healthcare
P/B-ratio voor Joinn Laboratories(China)Co.,Ltd. (603127)
P/B-ratio op October 2026 TTM: 3.72
Volgens de meest recente financiële rapporten en aandelenkoers van Joinn Laboratories(China)Co.,Ltd. is de huidige P/B-ratio (TTM) 3.72. Eind 2024 had het bedrijf een P/B-ratio van 1.52.
P/B-ratiohistoriek voor Joinn Laboratories(China)Co.,Ltd. van 2012 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 3.72 | 18.91% |
| 2025 | 3.13 | 105.36% |
| 2024 | 1.52 | -26.59% |
| 2023 | 2.08 | -45.67% |
| 2022 | 3.82 | -35.90% |
| 2021 | 5.96 | -68.75% |
| 2020 | 19.09 | 69.75% |
| 2019 | 11.24 | 34.73% |
| 2018 | 8.35 | 19.89% |
| 2017 | 6.96 | 63.38% |
| 2016 | 4.26 | -19.88% |
| 2015 | 5.32 | -23.41% |
| 2014 | 6.94 | -24.25% |
| 2013 | 9.17 | -15.74% |
| 2012 | 10.88 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 4.5801 | 23.06% |
US
|
|
| 3.0725 | -17.45% |
US
|
|
| 31.4903 | 746.08% |
US
|
|
| 4.9326 | 32.53% |
CN
|
|
| 6.8081 | 82.92% |
US
|
